therapies for aggressive cancer and leukemia. An
NF-kappa B inhibitor named dehydroxymethylepoxyquinomicin
Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQImportance of Novel Intraperitoneal Therapy of
NF-kappa B Inhibitor DHMEQ
Ahmad, S.,
Abbas, M.,
Ullah, M.F.,
Aziz, M.H.,
Beylerli, O.,
Alam, M.A.,
Syed, M.A.,
Uddin, S.,
Ahmad, A. (2022) ,
NF-κB signalling's involvement in cancer metastasis as a key inflammation-regulatory transcription